Want to join the conversation?
Maker of private label over-the-counter pharmaceuticals $PRGO said that it has acquired Matawan Pharmaceuticals' Retin-A (tretinoin) drug. The transaction is expected to immediately exceed $PRGO's ROIC threshold and add more than $0.20 in adjusted EPS within the first 12 months post-close after excluding certain items.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.